Latest Partnerships News

Archer Materials has achieved a significant milestone by integrating its graphene-based sensors with silicon readout circuitry, paving the way for a compact, at-home potassium testing device aimed at chronic kidney disease management.

Estrella Resources has initiated Timor-Leste’s inaugural modern metallic minerals drilling campaign, targeting manganese at the Ira Miri Prospect. This milestone marks a new chapter in the country’s mineral exploration history.

Aroa Biosurgery has reported FY25 results that exceed revenue guidance and deliver a positive normalised EBITDA, setting the stage for ambitious growth and reimbursement expansion in FY26.

Noxopharm has secured ethics approval to commence the HERACLES trial, marking the first human study of its novel SOF-SKN™ drug aimed at chronic inflammatory diseases.

Euro Manganese has successfully closed a C$11.2 million financing round, attracting heavyweight investors including the European Bank for Reconstruction and Development and Eric Sprott. The funds will accelerate development of its Chvaletice Manganese Project, a critical European source of battery-grade manganese.

Champion Iron Limited reported record quarterly sales and strong earnings in FY2025 Q4, while advancing its DRPF project on schedule and declaring its eighth consecutive dividend.

Gentrack Group has committed an additional AUD4.5 million to Amber’s AUD45 million funding round, reinforcing their strategic partnership to accelerate the global rollout of smart energy technologies.

HITIQ has secured a three-year deal with AFL Barwon to promote its PROTEQT smart mouthguard across regional Victoria, enhancing concussion management in community sports.

ReNerve Limited has gained marketing approval for its NervAlign® Nerve Cuff™ in Bahrain, marking its first regulatory success in the Middle East and opening access to a rapidly expanding regional market.

Epsilon Healthcare has emerged from Administration, securing expanded medicinal cannabis manufacturing permits and launching a new pharmacy brand as part of a strategic turnaround and growth plan.

RAS Technology Holdings has boosted its annualised recurring revenue to $21.1 million, driven by strategic acquisitions and a flurry of new contracts. The company’s expanding global footprint signals strong momentum heading into FY26.

Podium Minerals launches a $2.61 million rights issue to advance its Parks Reef PGM project, capitalising on strong market fundamentals and significant resource growth potential.